To obtain further evidence supporting the suppressive role of endogenous SPRED2 in HCC cell stemness, we examined the expression of pluripotency factors that drive stemness, such as Nanog, c-Myc and KLF4 [33,34]. The gene discussed is MYC; the disease is hepatocellular carcinoma.